GLP-1 Receptor Agonist Drugs Approved for Treatment of Diabetes and Obesity

20 March 2023

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

NOTICE PAPER NO. 1808
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON 20 MARCH 2023

Name and Constituency of Member of Parliament
Mr Melvin Yong Yik Chye
MP for Radin Mas SMC

Question No. 2840

To ask the Minister for Health (a) whether any GLP-1 receptor agonist drugs are currently approved for use to treat diabetes in Singapore; and (b) whether any of such class of drugs are under review to treat obesity, given the popularity of such drugs to treat obesity in countries such as the United States.

Answer

1 There are 3 GLP-1 receptor agonist drugs which have been approved for use in Singapore by the Health Sciences Authority (HSA) for the management of diabetes. Of these, 2 have also been approved by HSA for the purposes of obesity management.